Accordingly, common variants in IL1RL1 that associate with increased asthma risk associate with reduced expression of soluble ST2[38, 39], with the predicted effect being increased IL-33 activity, due to reduced level of this decoy receptor. This evidence concerns the gene IL33 and asthma.